Hager Mawlood Kowash

Dr. Hager Mawlood Kowash

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2023 in Neuronal Signaling
Verified
Journal Article
Open access
PDF file
RWRebecca M. Woods
Rebecca M. Woods
JLJarred M. Lorusso
Jarred M. Lorusso
JFJennifer Fletcher
Jennifer Fletcher
HEHeidi ElTaher
Heidi ElTaher
FMFrancesca McEwan
Francesca McEwan
JGJocelyn D. Glazier
Jocelyn D. Glazier
Maternal infection during pregnancy, leading to maternal immune activation (mIA) and cytokine release, increases the offspring risk of developing a variety of neurodevelopmental disorders (NDDs), including schizophrenia. Animal models have provided evidence to support these mechanistic links, with placental inflammatory responses and dysregulation of placental function implicated. This leads to changes in fetal brain cytokine balance and altered epigenetic regulation of key neurodevelopmental pathways. The prenatal timing of such mIA-evoked changes, and the accompanying fetal developmental responses to an altered in utero environment, will determine the scope of the impacts on neurodevelopmental processes. Such dysregulation can impart enduring neuropathological changes, which manifest subsequently in the postnatal period as altered neurodevelopmental behaviours in the offspring. Hence, elucidation of the functional changes that occur at the molecular level in the placenta is vital in improving our understanding of the mechanisms that underlie the pathogenesis of NDDs. This has notable relevance to the recent Covid-19 pandemic, where inflammatory responses in the placenta to SARS-CoV-2 infection during pregnancy and NDDs in early childhood have been reported. This review presents an integrated overview of these collective topics and describes the possible contribution of prenatal programming through placental effects as an underlying mechanism that links to NDD risk, underpinned by altered epigenetic regulation of neurodevelopmental pathways.

1 November 2019 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
HKHager Mawlood Kowash
Hager Mawlood Kowash
HPH.G. Potter
H.G. Potter
MEM.E. Edye
M.E. Edye
EPE.P. Prinssen
E.P. Prinssen
SBS. Bandinelli
S. Bandinelli
JGJ.D. Glazier
J.D. Glazier

15 November 2019 in Nature Communications
Verified
Journal Article
Open access
NANadine D. Arnold
Nadine D. Arnold
JPJosephine A. Pickworth
Josephine A. Pickworth
LWLaura E. West
Laura E. West
SDSarah Dawson
Sarah Dawson
JCJoana A. Carvalho
Joana A. Carvalho
ALAllan Lawrie
Allan Lawrie
Pulmonary arterial hypertension (PAH) is a rare but fatal disease. Current treatments increase life expectancy but have limited impact on the progressive pulmonary vascular remodelling that drives PAH. Osteoprotegerin (OPG) is increased within serum and lesions of patients with idiopathic PAH and is a mitogen and migratory stimulus for pulmonary artery smooth muscle cells (PASMCs). Here, we report that the pro-proliferative and migratory phenotype in PASMCs stimulated with OPG is mediated via the Fas receptor and that treatment with a human antibody targeting OPG can attenuate pulmonary vascular remodelling associated with PAH in multiple rodent models of early and late treatment. We also demonstrate that the therapeutic efficacy of the anti-OPG antibody approach in the presence of standard of care vasodilator therapy is mediated by a reduction in pulmonary vascular remodelling. Targeting OPG with a therapeutic antibody is a potential treatment strategy in PAH.

5 August 2022 in Clinical Science
Verified
Journal Article
Open access
PDF file
HKHager Mawlood Kowash
Hager Mawlood Kowash
HPHarry G. Potter
Harry G. Potter
RWRebecca M. Woods
Rebecca M. Woods
NANick Ashton
Nick Ashton
RHReinmar Hager
Reinmar Hager
JGJocelyn D. Glazier
Jocelyn D. Glazier
Maternal infection during pregnancy increases the offspring risk of developing a variety of neurodevelopmental disorders (NDDs), including schizophrenia. While the mechanisms remain unclear, dysregulation of placental function is implicated. We hypothesised that maternal infection, leading to maternal immune activation and stimulated cytokine production, alters placental and yolk sac amino acid transport, affecting fetal brain development and thus NDD risk. Using a rat model of maternal immune activation induced by the viral mimetic polyinosinic:polycytidylic acid (poly(I:C)), we investigated placental and yolk sac expression of system L amino acid transporter subtypes which transport several essential amino acids including branched-chain amino acids (BCAA), maternal and fetal BCAA concentration, placental 14C-leucine transport activity and associated impacts on fetal growth and development. Poly(I:C) treatment increased acutely maternal IL-6 and TNFα concentration, contrasting with IL-1β. Transcriptional responses for these pro-inflammatory cytokines were found in placenta and yolk sac following poly(I:C) treatment. Placental and yolk sac weights were reduced by poly(I:C) treatment, yet fetal body weight was unaffected, while fetal brain weight was increased. Maternal plasma BCAA concentration was reduced 24 h post-poly(I:C) treatment, yet placental, but not yolk sac, BCAA concentration was increased. Placental and yolk sac gene expression of Slc7a5, Slc7a8 and Slc43a2 encoding LAT1, LAT2 and LAT4 transporter subtypes respectively, was altered by poly(I:C) treatment. Placental 14C-leucine transport was significantly reduced 24 h post-treatment, contrasting with a significant increase six days following poly(I:C) treatment. Maternal immune activation induces dysregulated placental transport of amino acids affecting fetal brain development, and NDD risk potential in offspring.

7 March 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
RWRebecca Woods
Rebecca Woods
JLJarred M Lorusso
Jarred M Lorusso
IHIsabella Harris
Isabella Harris
HKHager Mawlood Kowash
Hager Mawlood Kowash
CMChris Murgatroyd
Chris Murgatroyd
RHReinmar Hager
Reinmar Hager
Exposure to maternal immune activation (MIA) in utero significantly elevates the risk of developing schizophrenia and other neurodevelopmental disorders. To understand the biological mechanisms underlying the link between MIA and increased risk, preclinical animal models have focussed on specific signalling pathways in the brain that mediate symptoms associated with neurodevelopmental disorders such as cognitive dysfunction. Reelin signalling in multiple brain regions is involved in neuronal migration, synaptic plasticity and long-term potentiation, and has been implicated in cognitive deficits. However, how regulation of Reelin expression is affected by MIA across cortical development and associated cognitive functions remains largely unclear. Using a MIA rat model, here we demonstrate cognitive deficits in adolescent object-location memory in MIA offspring and reductions in Reln expression prenatally and in the adult prefrontal cortex. Further, developmental disturbances in gene/protein expression and DNA methylation of downstream signalling components occurred subsequent to MIA-induced Reelin dysregulation and prior to cognitive deficits. We propose that MIA-induced dysregulation of Reelin signalling contributes to the emergence of prefrontal cortex-mediated cognitive deficits through altered NMDA receptor function, resulting in inefficient long-term potentiation. Our data suggest a developmental window during which attenuation of Reelin signalling may provide a possible therapeutic target.

29 August 2025 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
RWRebecca Woods
Rebecca Woods
HPHarry G. Potter
Harry G. Potter
HKHager Mawlood Kowash
Hager Mawlood Kowash
FMFrancesca McEwan
Francesca McEwan
IHIsabella Harris
Isabella Harris
RHReinmar Hager
Reinmar Hager
Maternal infection during pregnancy has been shown in epidemiological studies to increase the risk of neurodevelopmental disorders, like schizophrenia, in the developing fetus. Epigenetic mechanisms are thought to play a crucial role in linking maternal immune activation (MIA) to a higher risk of schizophrenia in offspring by disrupting normal brain development. However, our knowledge of how these epigenetic mechanisms are altered and contribute to abnormal neurodevelopment remains limited. This lack of understanding has slowed progress in identifying therapeutic targets in particular for cognitive symptoms of neurodevelopmental disorders. Focusing on the cortex of offspring exposed to MIA who showed cognitive impairments, at both prenatal and postnatal stages, here we measured tissue concentrations of S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH), using the SAM/SAH ratio as an indicator of overall methylation capacity. We also analyzed changes in the expression and activity of DNA methyltransferases (DNMTs), as well as DNA methylation (DNAm) patterns. Our findings revealed that MIA increased the SAM/SAH ratio and elevated both DNMT expression and activity in the fetal cortex. Surprisingly, these changes were not present after birth but resurfaced in adulthood, coinciding with cognitive deficits. These methylation pathway changes in adulthood were accompanied by altered DNAm patterns, with differentially methylated genes linked to schizophrenia risk and enriched in pathways related to neurodevelopment and neuronal signalling. These novel insights help establish a critical connection between MIA and epigenetic changes that contribute to cognitive deficits similar to those observed in schizophrenia.